Development of Silicone Elastomer-Based Composite Films Containing Ibuprofen and Functional Additives
Silicone elastomers are attractive matrices for transdermal drug delivery systems, but the controlled release of poorly water-soluble drugs from hydrophobic silicone networks remains challenging. Medical-grade silicone elastomers are generally regarded as chemically stable, biologically inert, and highly biocompatible polymer matrices, which supports their use in biomedical and pharmaceutical materials. Here, ibuprofen-loaded silicone/polyol composite films were prepared from hydroxyl-terminated polydimethylsiloxane (PDMS-OH) using glycerol- and 1,2-propylene glycol-derived alkoxysilane cross-linkers and amino-terminated PDMS as a metal-free room-temperature-vulcanising catalyst. The effects of cross-linker composition, glycerol, PEG 200 and selected functional additives on film formation, morphology, apparent ibuprofen release and preliminary Strat-M® permeation were evaluated. FTIR analysis indicated no covalent reaction between ibuprofen and the silicone network, but suggested hydrogen-bonding interactions with polyol-rich domains, particularly in glycerol-containing systems. Raman mapping supported ibuprofen incorporation within the films, while SEM showed phase-separated microdomains whose morphology depended on the formulation. Apparent release into 0.9% NaCl at 37 °C was formulation-dependent over 72 h. The optimised F-9 film showed approximately 83% cumulative apparent release, whereas the F-10 film containing copper oxide nanoparticles and sea buckthorn oil showed the highest numerical cumulative apparent release, approximately 94%. Kinetic analysis of the apparent release data supported a mainly diffusion-controlled contribution, modulated by hydrophilic microdomains. These results provide preliminary materials-development evidence that silicone/polyol films can be used to tune apparent ibuprofen release and merit further optimisation for local topical or transdermal applications; however, efficient skin permeation and biological performance require dedicated validation.
Authors
- Karen Khachatryan (ORCID: https://orcid.org/0000-0001-7823-5406)
- Gohar Khachatryan (ORCID: https://orcid.org/0000-0002-4601-7145)
- M. L. Atabekyan (ORCID: https://orcid.org/0000-0002-5265-5469)
- Stepan G. Grigoryan (ORCID: https://orcid.org/0000-0002-7193-9803)
- Vigen Topuzyan (ORCID: https://orcid.org/0000-0002-1721-1993)
- Zoya Farmazyan (ORCID: https://orcid.org/0000-0001-9841-5586)
- Nelly Avagyan
Institutions
- University of Agriculture in Krakow (PL)
- Institute of Fine Organic Chemistry of Scientific - Technological Center of Organic and Pharmaceutical Chemistry (AM)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2026-08-20
- DOI
- https://doi.org/10.3390/ijms27167446
- Primary Topic
- Advancements in Transdermal Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Science and Higher Education of the Russian Federation